MIV THERAPEUTICS INC

• Accepted (ET)
• Jul 12SC 13D/A—
  MIV THERAPEUTICS INC0000851909-11-000006 · 80.9 KB
  SEC(opens sec.gov)
• Feb 98-K—
  Current report0001183740-11-000122 · 7.3 KB
  SEC(opens sec.gov)
• Jan 58-K—
  Current report0001183740-11-000015 · 9.0 KB
  SEC(opens sec.gov)
• Nov 308-K—
  Current report0001183740-10-000733 · 760.1 KB
  SEC(opens sec.gov)
• Dec 108-K—
  Current report0001183740-09-000564 · 10.3 KB
  SEC(opens sec.gov)
• Apr 88-K—
  Current report0001183740-09-000166 · 10.1 KB
  SEC(opens sec.gov)
• Mar 108-K—
  Current report0001183740-09-000091 · 165.4 KB
  SEC(opens sec.gov)
• Jan 2010-Q—
  Quarterly update0001183740-09-000029 · 272.0 KB
  SEC(opens sec.gov)
• Apr 1110-Q—
  Quarterly update0001019687-08-001598 · 144.5 KB
  SEC(opens sec.gov)
• Jan 244/A—
  MIV THERAPEUTICS INC0001303600-08-000005 · 25.5 KB
  SEC(opens sec.gov)

• Landy MarkDirector, President
• LINDSAY ALAN PDirector, Chairman
• MCGOWAN PATInsider
• MIV THERAPEUTICS INCInsider

No tickers on record.

• business

  1-8765 ASH STREET

  VANCOUVER BC CANADA, A1, V6P 6T3

• mailing

  1-8765 ASH STREET

  VANCOUVER BC CANANDA, A0, V6P 6T3

• DBS HOLDINGS INC2002-01-22